| 产品名称： | Cryptococcus neoformans (Sanfelice) Vuillemin |
|---|---|
| 商品货号： | TS167068 |
| Deposited As： | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
| Strain Designations： | 145 |
| Alternate State： | Filobasidiella neoformans Kwon-Chung |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2 highly virulent ref
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Antigenic Properties： | serotype A, serotype A
Ref  Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677, RefLevitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 |
| Preceptrol®： | no |
| Comments： | medium capsule |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | TG Mitchell |
| Chain of Custody： | ATCC < |
| Isolation： | human spinal fluid |
| References： | Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 Mukherjee S, et al. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173: 1222-1231, 1996. PubMed: 8627076 Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 Olszewski MA, et al. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69: 6256-6263, 2001. PubMed: 11553568 Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Cryptococcus neoformans (Sanfelice) Vuillemin |
|---|---|
| 商品货号： | TS167068 |
| Deposited As： | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
| Strain Designations： | 145 |
| Alternate State： | Filobasidiella neoformans Kwon-Chung |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2 highly virulent ref
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Antigenic Properties： | serotype A, serotype A
RefMitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677, RefLevitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 |
| Preceptrol®： | no |
| Comments： | medium capsule |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | TG Mitchell |
| Chain of Custody： | ATCC < |
| Isolation： | human spinal fluid |
| References： | Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 Mukherjee S, et al. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173: 1222-1231, 1996. PubMed: 8627076 Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 Olszewski MA, et al. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69: 6256-6263, 2001. PubMed: 11553568 Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677 Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 |
